Fundraising FoxAltor Bioscience
Miramar, US · Delaware corporation · 3 known investors
Find your way into Altor Bioscience
Sign up to see every warm intro you have to Altor Bioscience
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Altor Bioscience team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
HC
Hing C WongFounder
PR
Peter RhodeExecutive
Board
AW
Adam WaldmanBoard director
FM
Fred MiddletonBoard directorManaging Director at Sanderling Ventures
CB
C. Boyder GrayBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$61M disclosed across 3 rounds · 2014–2017
▶$30.3MraisedMar 2017 · 7 investors · BiotechnologyRule 506(b)
▶$30.3MraisedMar 2017 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter RhodeExecutive Officer
- Fred MiddletonDirector
- Rick S. GreeneExecutive Officer
- Patrick Soon-ShiongDirector
- Hing C. WongExecutive Officer, Director
- Offering amount
- $30.3M
- Amount sold
- $30.3M
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20MraisedJul 2016 · 1 investors · BiotechnologyRule 506(b)
▶$20MraisedJul 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Hing C. WongExecutive Officer, Director
- Peter RhodeExecutive Officer
- Rick S. GreeneExecutive Officer
- Fred MiddletonDirector
- Patrick Soon-ShiongDirector
- Offering amount
- $45M
- Amount sold
- $20M
- Minimum investment
- $15K
- Proceeds to insiders
- $5.8M
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10.7MraisedJun 2015 · 1 investors · BiotechnologyRule 506(b)
▶$10.7MraisedJun 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Hing C WongExecutive Officer, Director
- Adam WaldmanDirector
- Fred MiddletonDirector
- C. Boyder GrayDirector
- Peter RhodeExecutive Officer
- Offering amount
- $10.7M
- Amount sold
- $10.7M
- First sale
- Oct 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
TargetedoncTargeted Oncology is a medical news and education publication for oncologists and cancer care professionals, covering clinical trial data, FDA approvals, treatment guidelines, and expert commentary across cancer types. It delivers conference coverage, podcasts, videos, and short-form content focused on precision oncology and targeted cancer therapies.
Companies working in the same space as Altor Bioscience.
Frequently asked questions
- Who founded Altor Bioscience?
- Altor Bioscience was founded by Hing C Wong.
- Who are Altor Bioscience's investors?
- Altor Bioscience's investors include New World Angels, Oberland Capital, Sanderling Ventures.
- How much funding has Altor Bioscience raised?
- Altor Bioscience has disclosed $61M raised across 3 rounds.
- Where is Altor Bioscience headquartered?
- Altor Bioscience is headquartered in Miramar, US.